Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.

Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients.

The beneficial effect of blood transfusion and the DR 1 gene dose on renal transplant outcome in blacks.

Impaired fibrinolysis and risk of thromboembolism.

Beneficial effect of conversion to belatacept in kidney-transplant patients with a low glomerular-filtration rate.

Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients.

Sporotrichosis in renal transplant patients.

Tuberculosis in renal transplant patients.

Examination of the effect of changing to azilsartan from candesartan in renal transplant patients.

Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.

Effect of activated protein C on impaired fibrinolysis in rats with obstructive jaundice.

Aminoglycosides in patients with impaired renal function.

The Effect of Different Glycaemic States on Renal Transplant Outcomes.

Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.

Hepatitis B in renal transplant patients.

Calyceal-cutaneous fistulae in renal transplant patients.

Herpes simplex keratitis in renal transplant patients.

Herpes simplex keratitis in renal transplant patients.

Serum leptin in renal transplant patients.

Presurgical pulmonary evaluation in renal transplant patients.

Massive skeletal trauma in renal transplant patients.

Plasma lipoproteins in renal transplant patients.

Effect of periodontal treatment in renal transplant recipients.

Neurocognitive functions in pediatric renal transplant patients.

Aortoiliac surgery in renal transplant patients.

Suggest Documents

Impaired fibrinolysis and postoperative thromboembolism in orthopedic patients.

The beneficial effect of blood transfusion and the DR 1 gene dose on renal transplant outcome in blacks.

Impaired fibrinolysis and risk of thromboembolism.

Beneficial effect of conversion to belatacept in kidney-transplant patients with a low glomerular-filtration rate.

Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients.

Sporotrichosis in renal transplant patients.

Tuberculosis in renal transplant patients.

Examination of the effect of changing to azilsartan from candesartan in renal transplant patients.

Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients.

Effect of activated protein C on impaired fibrinolysis in rats with obstructive jaundice.

Aminoglycosides in patients with impaired renal function.

The Effect of Different Glycaemic States on Renal Transplant Outcomes.

Effect of active infection on cytochrome P450-mediated metabolism of cyclosporine in renal transplant patients.

Hepatitis B in renal transplant patients.

Calyceal-cutaneous fistulae in renal transplant patients.

Herpes simplex keratitis in renal transplant patients.

Herpes simplex keratitis in renal transplant patients.

Serum leptin in renal transplant patients.

Presurgical pulmonary evaluation in renal transplant patients.

Massive skeletal trauma in renal transplant patients.

Plasma lipoproteins in renal transplant patients.

Effect of periodontal treatment in renal transplant recipients.

Neurocognitive functions in pediatric renal transplant patients.

Aortoiliac surgery in renal transplant patients.

Impaired fibrinolysis in cyclosporine-treated renal transplant patients. Analysis of the defect and beneficial effect of fish-oil.

Recommend Documents

Follow Us